US Broker Ratings

Bausch + Lomb Corporation (BLCO) Stock Analysis: Insight into a Healthcare Giant with a Global Reach

Bausch + Lomb Corporation (NYSE: BLCO) is a notable player in the healthcare sector, specifically within the medical instruments and supplies industry. With a rich history..

Nuvalent, Inc. (NUVL) Stock Analysis: Unpacking the 35.92% Potential Upside for Biotech Investors

Nuvalent, Inc. (NASDAQ: NUVL) is an exciting player in the biotechnology sector, drawing attention with a market capitalization of $8.1 billion. Headquartered in Cambridge, Massachusetts, Nuvalent..

Oscar Health (OSCR) Stock Analysis: Navigating the Healthcare Sector with a 23.20% Revenue Growth

Oscar Health, Inc. (NYSE: OSCR) stands as a dynamic player in the healthcare plans industry, offering innovative solutions to a broad range of clients. Headquartered in..

BeOne Medicines Ltd. (ONC)

⚠️ No article content returned.

..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Navigating Growth with a Robust 23.7% Revenue Surge

Medpace Holdings, Inc. (NASDAQ: MEDP), a formidable player in the healthcare sector, has recently captured investor attention with its impressive 23.7% revenue growth. Specializing in diagnostics..

Globus Medical, Inc. (GMED) Stock Analysis: Navigating a 13.83% Potential Upside with Innovative Medical Solutions

Globus Medical, Inc. (NYSE: GMED), a renowned player in the healthcare sector, particularly in the medical devices industry, presents a compelling opportunity for investors seeking growth..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Uncovering a Potential 46.74% Upside in the Biotech Arena

TG Therapeutics, Inc. (NASDAQ: TGTX) stands out in the biotechnology sector, capturing the attention of investors with its innovative approach to tackling B-cell mediated diseases. With..

Revolution Medicines (RVMD) Stock Analysis: Navigating the RAS-Driven Cancer Market with a $23.25 Billion Valuation

Revolution Medicines, Inc. (NASDAQ: RVMD) is making waves in the biotechnology sector with its innovative approach to combat RAS-driven cancers. As a clinical-stage precision oncology company,..

Royalty Pharma plc (RPRX) Stock Analysis: Navigating Substantial Upside Potential with a 17.95% Forecasted Increase

Royalty Pharma plc (NASDAQ: RPRX) stands out as a unique player in the biotechnology sector, with a business model that revolves around acquiring biopharmaceutical royalties and..

AptarGroup, Inc. (ATR) Stock Report: Exploring a 27.61% Upside with Strong Analyst Ratings

AptarGroup, Inc. (NYSE: ATR), a formidable player in the medical instruments and supplies industry, is garnering investor attention with a promising 27.61% potential upside, as indicated..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating a 17.27% Potential Upside in the Medical Devices Sector

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) stands as a significant player in the medical devices industry, with a robust market cap of $17.3 billion. As a..

Pfizer, Inc. (PFE) Stock Analysis: Navigating a 6.71% Dividend Yield Amid Market Challenges

Pfizer, Inc. (NYSE: PFE), a titan in the global pharmaceutical industry, presents a compelling investment case with its substantial market presence and robust dividend yield. As..

Chemed Corp (CHE) Stock Analysis: A 27% Upside Potential with Strong Analyst Support

Chemed Corp (NYSE: CHE), a prominent player in the healthcare sector, operates through two distinct segments: VITAS, which provides hospice and palliative care services, and Roto-Rooter,..

Regencell Bioscience Holdings L (RGC) Investor Outlook: Examining the Potential in Traditional Chinese Medicine Bioscience

Regencell Bioscience Holdings Limited (RGC) stands at a unique intersection of healthcare and traditional Chinese medicine (TCM), offering a compelling narrative for investors interested in innovative..

United Therapeutics Corporation (UTHR): Investor Outlook with a 14.18% Potential Upside

United Therapeutics Corporation (NASDAQ: UTHR), a pioneering entity in the healthcare sector, specifically within the drug manufacturing niche for specialty and generic medications, presents an intriguing..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: A 31.97% Potential Upside in the Healthcare Device Sector

Investors in the healthcare sector, particularly those with a focus on medical devices, may find iRhythm Holdings, Inc. (NASDAQ: IRTC) a compelling consideration. As a leader..

ADMA Biologics Inc (ADMA) Stock Analysis: Exploring a Potential 48% Upside in the Biotech Sector

ADMA Biologics Inc (NASDAQ: ADMA) is drawing significant attention within the healthcare sector, especially among investors keen on biotechnology stocks. The company, with a market cap..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Unveiling a 16.64% Potential Upside in Biotechnology

BridgeBio Pharma, Inc. (BBIO) is making waves in the biotechnology sector with its innovative approach to addressing genetic diseases and cancers. As a commercial-stage biopharmaceutical company,..

Charles River Laboratories (CRL) Stock Analysis: Navigating the Healthcare Sector with Strategic Collaborations

Charles River Laboratories International, Inc. (NYSE: CRL), a prominent player in the healthcare sector, is attracting significant attention from investors with its strategic alliances and specialized..

Teleflex Incorporated (TFX) Stock Analysis: Navigating a Potential 27% Upside in a Challenging Market

Teleflex Incorporated (NYSE: TFX), a stalwart in the healthcare sector, stands at a pivotal juncture. The company, known for its innovative medical instruments and supplies, has..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds